-

10:25:42 PM

APDN Stock News

APDN - Applied Dna Sciences Inc

10/20/21 12:01 AM

Nasdaq : APDN

Ganesha Ecosphere and Applied DNA to Deploy CertainT® Platform to Secure Recycled Polyester Supply Chain

Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction- based DNA manufacturing and nucleic acid-based technologies, today announced signing a mutual collaboration agreement with Ganesha Ecosphere Ltd., the largest recycled polyester fiber producer in India with over 300- plus customers, 250- plus suppliers, and...

RHEA-AI

neutral

10/12/21 10:15 AM

Nasdaq : APDN

covid-19

Applied DNA Implements safeCircle™ COVID-19 Testing Program at Sarah Lawrence College

Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction- based DNA manufacturing and nucleic acid-based technologies, announced that safeCircle™, its high-throughput, pooled COVID-19 testing program, has been implemented at Sarah Lawrence College as an addition to the College’ s in-house testing practice to monitor for the prevalence of COVID-19...

RHEA-AI

neutral

09/27/21 10:30 AM

Nasdaq : APDN

Applied DNA Receives Purchase Orders Totaling $1.6 Million to Tag Textile Fibers

Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction- based DNA manufacturing and nucleic acid-based technologies, today announced that it received purchase orders from a textile customer totaling $1.6 million to supply molecular taggant to tag textile fibers. These projects include textiles of multiple fibers with customer operations in...

RHEA-AI

neutral

09/14/21 8:00 AM

Nasdaq : APDN

Applied DNA Announces CertainT® Platform Support for TruTrace StrainSecure™ 2.0 for Next Generation Cannabis Tagging, Testing and Tracking

Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction- based DNA manufacturing and nucleic acid-based technologies, today announced that its CertainT ® platform has added support for StrainSecure 2.0 by TruTrace Technologies, Inc. that builds on the companies’ strategic sales, marketing, and technology integration partnership to advance...

RHEA-AI

positive

09/08/21 9:00 AM

Nasdaq, OTC : APDN, FLGC, TTTSF

Applied DNA Enters into Master Services Agreement with Flora Growth for Cannabis Validation and Authentication, Secures First Statement of Work Contract

Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction- based DNA manufacturing and nucleic acid-based technologies, today announced that it has entered into a Master Services Agreement with Flora Growth to deploy the Company’ s CertainT ® platform as part of Flora’ s global cannabis product validation and authentication platform for consumers,...

RHEA-AI

very positive

09/07/21 8:00 AM

Nasdaq : APDN

conferences

Applied DNA to Participate at H.C. Wainwright 23rd Annual Global Investment Conference

Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction- based DNA manufacturing and nucleic acid-based technologies, today announced that Dr. Wainwright 23 rd Annual Global Investment Conference to be held virtually from September 13– 15, 2021.. A webcast of the virtual presentation will be available starting at 7:00 am on September 13, 2021, and...

RHEA-AI

neutral

09/02/21 6:00 AM

Nasdaq : APDN

covid-19

Applied DNA Awarded Suffolk County Community College COVID-19 Testing Contract

Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction- based DNA manufacturing and nucleic acid-based technologies, today announced that its wholly-owned subsidiary, Applied DNA Clinical Labs, LLC, was awarded a testing contract by Suffolk County Community College to monitor for the prevalence of COVID-19 among its unvaccinated staff and...

RHEA-AI

neutral

08/12/21 4:05 PM

Nasdaq, OTC : APDN, APPDW

earnings

Applied DNA Announces Third Quarter Fiscal 2021

Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, today announced consolidated financial results for the three and nine months ended June 30, 2021.“We delivered excellent

RHEA-AI

neutral

08/05/21 10:00 AM

Nasdaq : APDN

earnings

Applied DNA Schedules Fiscal 2021 Third Quarter Financial Results Conference Call and Webcast for Thursday, August 12, 2021

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)- based DNA manufacturing and nucleic acid-based technologies, today announced that it will report fiscal 2021 third quarter financial results after market close on Thursday,

RHEA-AI

neutral

08/03/21 12:25 PM

Nasdaq : APDN

covid-19

Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract

Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, today announced that its wholly-owned subsidiary, Applied DNA Clinical Labs, LLC, (ADCL) was awarded a competitively-bid

RHEA-AI

neutral

1 2 3 4 5 6 7 Next

APDN Data:

IndustryCyclic Crude, Intermediate, and Gum and Wood Chemical Manufacturing
Websitehttps://adnas.com
CeoJames Hayward
Security nameApplied Dna Sciences Inc
Issue typecs
SectorManufacturing
Sic code2865
Employees60
Tags
- Manufacturing
- Technology Services
- Cyclic Crude
- Intermediate
- and Gum and Wood Chemical Manufacturing
- Health Technology
- Pharmaceuticals: Major
- Miscellaneous Commercial Services
- Commercial Services
- Information Technology Services
Address50 Health Sciences Dr
StateNew York
CityStony Brook
Zip11790-3349
CountryUS
Phone16312408800

APDN Description:

Applied DNA is commercializing LinearDNA™, its proprietary, large-scale polymerase chain reaction ('PCR')-based manufacturing platform that allows for the large-scale production of specific DNA sequences. The LinearDNA platform has utility in the nucleic acid-based in vitro diagnostics and preclinical nucleic acid-based drug development and manufacturing market. The platform is used to manufacture DNA for customers as components of in vitro diagnostic tests and for preclinical nucleic acid-based drug development in the fields of adoptive cell therapies (CAR T and TCR therapies), DNA vaccines (anti-viral and cancer), RNA therapies, clustered regularly interspaced short palindromic repeats (CRISPR) based therapies, and gene therapies. Applied DNA has also established a COVID-19 diagnostic and testing offering that is in the early stages of commercialization and is grounded in the Company's deep expertise in DNA. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others.